Firms negotiate discounts, or rebates, down from the list price drugmakers set. Critics argue the practice inflates drug prices because it encourages manufacturers to set higher prices.
Former Celgene CEO Bob Hugin is trying to take down scandal-wracked New Jersey Sen. Bob Menendez in what could become a nasty race.
While signing "right-to-try" legislation into law, Trump touted his administration's moves to lower prescription drug prices.
Biotech companies and pharmacy benefit managers are outperforming the market, despite new pressure on drugmakers.
President Donald Trump unveiled his blueprint to lower drug prices, called "American Patients First," in a highly anticipated speech on Friday. However, his actions weren't as biting as his words suggested.
"Just raising the prices across the world isn't going to help America," former Health and Human Services Secretary Tommy Thompson says.
President Donald Trump criticized middlemen and other companies along the drug supply chain in a speech touting proposals to lower prescription prices.
HHS Secretary Alex Azar says the Trump administration will try to change incentives that reward higher list prices.
President Trump is expected to unveil his administration's plan to lower drug prices in a speech Friday afternoon.
The plan, set to be released Friday, includes a number of provisions including require Medicare Part D plan share rebates with patients.
President Trump is preparing to deliver a long-awaited address on prescription drug prices as soon as next week, but advocates warn the White House may be focused more on populist messaging than swallowing bitter pills, USA Today reported.
The theme was present this week at the World Health Care Congress.
It's been a campaign promise going back to 2015, from both sides of the political aisle, but nothing substantial has changed.
Trump wants to do more to address drug prices, HHS Secretary Alex Azar tells the World Health Care Congress.
Lawmakers aren't likely to tackle the Affordable Care Act until after midterm elections, former Health and Human Services Secretary Tom Price says.
Opioid-dependent people are "individuals who are getting trapped in a cycle of addiction," HHS' Alex Azar argues.
FDA Commissioner Scott Gottlieb criticized the U.S. system for pricing and paying for drugs more broadly.
President Donald Trump has repeatedly said he wants to see prescription drug prices reduced.